Pre-onlines

Evidence evaluation in rare disease guidelines: a methodological perspective

DOI: 10.20517/rdodj.2025.29 28 Oct 2025

Neurofibromatosis type 2-related schwannomatosis: an update

DOI: 10.20517/rdodj.2025.11 29 Oct 2025

A communication toolkit for the most impactful symptoms of Fabry disease: co-creation with Fabry disease patients and their treating clinicians in the UK

DOI: 10.20517/rdodj.2025.27 29 Oct 2025

Monoclonal gammopathies and their management in Gaucher disease type 1

 

DOI: 10.20517/rdodj.2025.30 28 Oct 2025

Management strategies for systemic lupus erythematosus using kinase inhibitors

DOI: 10.20517/rdodj.2025.08 3 Nov 2025

Emerging treatments for systemic lupus erythematosus

DOI: 10.20517/rdodj.2025.45 3 Nov 2025
Rare Disease and Orphan Drugs Journal
ISSN 2771-2893 (Online)
Follow Us

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/